Gerard Ber's Insider Trades & SAST Disclosures
Gerard Ber's most recent trade in Y-Mabs Therapeutics Inc was a trade of 722 Common Stock done at an average price of $12 . Disclosure was reported to the exchange on June 10, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gerard Ber.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Gerard Ber | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 10 Jun 2024 | 722 | 1,608 (0%) | 0% | 12 | 8,664 | Common Stock |
| Y-Mabs Therapeutics Inc | Gerard Ber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 16,000 | 16,000 | - | - | Non-Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Gerard Ber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 16,000 | 16,000 | - | - | Non-Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Gerard Ber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 16,000 | 16,000 | - | - | Non-Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges